600380 健康元
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入11,477,807-3.54%15,619,48016,646,35017,142,75315,903,688
减:营业总成本8,763,958-3.92%11,986,20213,123,51613,784,93813,169,413
    其中:营业成本4,254,948-3.16%5,827,8536,298,4666,252,2655,716,294
               财务费用(262,734)147.93%(301,975)(404,841)(352,447)(92,895)
               资产减值损失(20,885)-81.63%(293,144)(312,370)(142,628)(62,951)
公允价值变动收益3,331-158.07%(17,496)(25,420)(76,263)(23,506)
投资收益64,82725.51%64,37179,47555,97371,881
    其中:对联营企业和合营企业的投资收益59,37072.74%27,08072,79470,57810,281
营业利润2,870,8721.36%3,616,2843,506,5653,479,9362,983,067
利润总额2,852,7361.19%3,574,8873,465,5553,456,1052,952,329
减:所得税费用408,1745.85%592,141614,536561,797339,480
净利润2,444,5610.45%2,982,7462,851,0192,894,3082,612,849
减:非控股权益1,353,3472.36%1,596,1761,408,2391,391,5311,284,350
股东净利润1,091,214-1.83%1,386,5701,442,7801,502,7771,328,499

市场价值指针
每股收益 (元) *0.6001.69%0.7400.7600.7930.686
每股派息 (元) *----0.2000.1800.1800.150
每股净资产 (元) *8.1265.12%7.7557.3746.8026.196
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容